88 related articles for article (PubMed ID: 1984840)
1. c-myc and K-ras-2 oncogenes in B-cell chronic lymphocytic leukemia with del(12)(p13).
Wang TY; Samples DM; Dabdoub R; Prakash O
Cancer Genet Cytogenet; 1991 Jan; 51(1):125-30. PubMed ID: 1984840
[TBL] [Abstract][Full Text] [Related]
2. Establishment of cell lines derived from chronic lymphocytic leukaemic cells by transfection with myc and ras.
Zheng CY; Pabello P; Maksymiuk AW; Skinnider LF
Br J Haematol; 1996 Jun; 93(3):681-3. PubMed ID: 8652393
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course.
Put N; Van Roosbroeck K; Konings P; Meeus P; Brusselmans C; Rack K; Gervais C; Nguyen-Khac F; Chapiro E; Radford-Weiss I; Struski S; Dastugue N; Gachard N; Lefebvre C; Barin C; Eclache V; Fert-Ferrer S; Laibe S; Mozziconacci MJ; Quilichini B; Poirel HA; Wlodarska I; Hagemeijer A; Moreau Y; Vandenberghe P; Michaux L;
Ann Hematol; 2012 Jun; 91(6):863-73. PubMed ID: 22205151
[TBL] [Abstract][Full Text] [Related]
4. Transfection of chronic lymphocytic leukemic cells with myc and ras.
Zheng CY; Skinnider LF; Xian J; Maksymiuk A
Leukemia; 1992; 6 Suppl 3():34S-37S. PubMed ID: 1602824
[TBL] [Abstract][Full Text] [Related]
5. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
6. Amplification of c-MYC oncogene and point mutation of N-RAS oncogene point mutation in acute myelocytic leukemias with double minute chromosomes.
Tanaka K; Takechi M; Nishimura S; Oguma N; Kamada N
Leukemia; 1993 Mar; 7(3):469-71. PubMed ID: 8445953
[TBL] [Abstract][Full Text] [Related]
7. Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia.
Brown JR; Hanna M; Tesar B; Werner L; Pochet N; Asara JM; Wang YE; Dal Cin P; Fernandes SM; Thompson C; Macconaill L; Wu CJ; Van de Peer Y; Correll M; Regev A; Neuberg D; Freedman AS
Clin Cancer Res; 2012 Jul; 18(14):3791-802. PubMed ID: 22623730
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
9. 11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules.
Dickinson JD; Gilmore J; Iqbal J; Sanger W; Lynch JC; Chan J; Bierman PJ; Joshi SS
Leuk Lymphoma; 2006 Feb; 47(2):231-44. PubMed ID: 16321852
[TBL] [Abstract][Full Text] [Related]
10. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
[TBL] [Abstract][Full Text] [Related]
11. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
[TBL] [Abstract][Full Text] [Related]
12. Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.
Kozma L; Kiss I; Nagy A; Szakáll S; Ember I
Cancer Lett; 1997 Jan; 111(1-2):127-31. PubMed ID: 9022137
[TBL] [Abstract][Full Text] [Related]
13. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
[TBL] [Abstract][Full Text] [Related]
14. [Molecular cytogenetic characteristics of chronic lymphocytic leukemia].
Xu W; Li JY; Pan JL; Qiu HR; Shen YF; Xiao B; Chen LJ; Wu YF; Sheng RL; Xue YQ
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):349-52. PubMed ID: 17044998
[TBL] [Abstract][Full Text] [Related]
15. Deletion of chromosome 13 (band q14) but not trisomy 12 is a clonal event in B-chronic lymphocytic leukaemia (CLL).
Jabbar SA; Ganeshaguru K; Wickremasinghe RG; Hoffbrand AV; Foroni L
Br J Haematol; 1995 Jun; 90(2):476-8. PubMed ID: 7794777
[TBL] [Abstract][Full Text] [Related]
16. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
17. Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab.
Byrd JC; Smith L; Hackbarth ML; Flinn IW; Young D; Proffitt JH; Heerema NA
Cancer Res; 2003 Jan; 63(1):36-8. PubMed ID: 12517774
[TBL] [Abstract][Full Text] [Related]
18. Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis.The Tampere Chronic Lympocytic Leukemia group.
Larramendy ML; Siitonen SM; Zhu Y; Hurme M; Vilpo L; Vilpo JA; Knuutila S
Cytogenet Cell Genet; 1998; 82(3-4):215-21. PubMed ID: 9858820
[TBL] [Abstract][Full Text] [Related]
19. Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature.
Reddy K; Satyadev R; Bouman D; Hibbard MK; Lu G; Paolo R
Cancer Genet Cytogenet; 2006 Apr; 166(1):12-21. PubMed ID: 16616107
[TBL] [Abstract][Full Text] [Related]
20. Del(3)(p13) in B-prolymphocytic leukemia--a new nonrandom chromosomal aberration possibly related to the c-ras oncogene.
Juliusson G; Robèrt KH; Ost A; Friberg K; Biberfeld P; Zech L; Gahrton G
Cancer Genet Cytogenet; 1985 Jan; 14(3-4):191-5. PubMed ID: 3871348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]